Application of disitamab vedotin in the multiline treatment of EGFR mutation-positive lung adenocarcinoma with Her-2 overexpression - Lan, Meiling; Wang, Tianyun; Luo, Diexiao; Chen, Yan; Liang, Wei; Kong, Rui; Xie, Qichao (Frontiers in Oncology, 2024)